Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02298270 · ClinicalTrials.gov registry record · NA
Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT02298270: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02298270 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02298270, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
This study tests the efficacy of an 8-week, Skype-based, group resiliency training intervention (The Relaxation Response Resiliency Program) for improving psychological stress in patients with Neurofibromatosis. A control group will receive a general health education curriculum. The investigators hypothesize that patients will improve on measures of psychological stress as a result of the resiliency program. A substudy (Unique Protocol ID: 2013P002605b) has been approved to test this study on a sub-population: patients with NF2 who are hard of hearing.
Interventions
- BEHAVIORAL The Relaxation Response Resiliency Program (3RP) via Skype
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02298270
The ClinicalTrials.gov registry entry for NCT02298270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The Relaxation Response Resiliency Program (3RP) via Skype is the first listed.
NCT02298270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02298270 about?
NCT02298270 is a clinical study titled "Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype". This study tests the efficacy of an 8-week, Skype-based, group resiliency training intervention (The Relaxation Response Resiliency Program) for improving psychological stress in patients with Neurofibromatosis. A control group will receive a general health education curriculum. The investigators hy...
What is the current status of trial NCT02298270?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2014-03. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02298270?
The interventions under investigation include: The Relaxation Response Resiliency Program (3RP) via Skype (BEHAVIORAL).
Who is sponsoring clinical trial NCT02298270?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.